NCT07435155 ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment
| NCT ID | NCT07435155 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Salamanca |
| Condition | Dysarthria |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-15 |
| Primary Completion | 2026-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-10-15 with a primary completion date of 2026-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to describe speech and breathing patterns in adults after acquired brain injury (ABI) and understand how these patterns relate to the presence, severity, and type of dysarthria. The main questions it aims to answer are: * What changes in voice and breathing are observed in adults with dysarthria after ABI? * Can combining acoustic, respiratory, and clinical assessments help identify dysarthria severity and subtype? Participants will: * Have their speech recorded to measure voice and articulation features, such as pitch, clarity, and the ability to sustain sounds. * Perform breathing tests using a spirometer to assess lung function. * Complete the Frenchay Dysarthria Assessment-2 (FDA-2), adapted to Spanish, to classify dysarthria type and severity. About 97 to 101 participants will take part. The results will help speech therapists better detect, evaluate, and treat dysarthria in adults after brain injury.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older at the time of enrollment. Diagnosed with acquired brain injury (ABI), including: * Stroke * Traumatic brain injury (TBI) * Brain tumor * Ability to provide written informed consent (or via a legally authorized representative if necessary). * Cognitive function preserved, defined as a Mini-Mental State Examination (MMSE) score ≥ 24. Exclusion Criteria: * History of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) or asthma. * History of hearing impairments that could affect speech evaluation. * Presence of additional neurological or neurodegenerative disorders other than the acquired brain injury. * History of voice disorders or dysphonia prior to the acquired brain injury. * Presence of persistent pharyngeal symptoms, such as mucus, secretions, or foreign body sensation, which may interfere with speech assessment. * Participants unable to comply with the assessment protocol or complete the required sessions. * Presence of apahasia that prevents participation in speech tasks, such as reading, repetition, or spontaneous speech priduction.
Contact & Investigator
Ana-María Martín Nogueras, Investigator/ Profesor
PRINCIPAL INVESTIGATOR
University of Salamanca
Frequently Asked Questions
Who can join the NCT07435155 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dysarthria. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07435155 currently recruiting?
Yes, NCT07435155 is actively recruiting participants. Contact the research team at ahmedargoubi@usal.es for enrollment information.
Where is the NCT07435155 trial being conducted?
This trial is being conducted at Salamanca, Spain.
Who is sponsoring the NCT07435155 clinical trial?
NCT07435155 is sponsored by University of Salamanca. The principal investigator is Ana-María Martín Nogueras, Investigator/ Profesor at University of Salamanca. The trial plans to enroll 100 participants.